The increased development and availability of New Approach Methodologies (NAMs) provide a path towards more sustainable, human relevant, and mechanistically based strategies for chemical hazard and risk assessment [1]. However, their regulatory uptake in this context remains limited and further efforts for building confidence in NAM use for decision making are still required [2]. In the context of PARC (European Partnership for the Assessment of Risk from Chemicals) we investigate how NAM-based approaches as well as NAM-derived evidence may support hazard and risk assessment by conducting a coordinated series of case studies that explore key regulatory contexts, purposes, and targeted toxicological endpoints. The purpose is to test NAM-based strategies in realistic decision scenarios to clarify whether implementation is already feasible, in which cases methodological refinements are still required and to define key criteria to ensure their regulatory relevance. The findings are designed to strengthen regulatory acceptance by providing rigorously structured and fully transparent demonstrations of how the NAM-based approaches can be applied across various regulatory contexts (e.g., Occupational Safety and Health directives, Plant Protection Products, CLP and REACH regulations) [3]. The project collects nine case study (CS) proposals designed considering key elements, such as biological coverage, predictivity, chemical applicability domain and the evaluation of data gaps and uncertainties, to ensure the applicability and added value of the NAM-based approaches for regulatory decision-making. All CSs are categorized according to their intended regulatory use, including quantitative in-vitro to in-vivo extrapolation, screening/ prioritization, point-of-departure derivation and specific toxicological endpoints (e.g., carcinogenicity, developmental neurotoxicity, endocrine toxicity, respiratory irritation, developmental and reproductive toxicity). A structured set of guiding questions is established to refine the CSs, with strong emphasis on key aspects such as data availability, harmonized use of data quality assessment tools, evaluation of method reliability, relevance and readiness according to OECD Guidance Document 34, chemical selection criteria, data modelling and integration strategies, and the regulatory relevance of the expected results. Overall, the project will work towards building a structured and pragmatic framework for implementing NAMs into regulatory hazard and risk assessment. Ongoing dialogue with regulatory stakeholders will ensure alignment with regulatory expectations [4]. The project will also describe priority areas for advancing NAM uptake, including the need for robust evaluation criteria and increased regulatory harmonization, while informing the consideration of NAM-based approaches within the OECD Test Guideline Programme. This project is co-funded by PARC (European Partnership for the Assessment of Risk from Chemicals).
Integrating New Approach Methodologies (NAMs) into regulatory workflows: insights from a series of Case Studies / Catinari, C., Bajard, L.M., Battistelli, C.L., Beronius, A., Boos, J., Bossa, C., Deepika, D., De Paula Souza, J., Fritsche, E., Kumar, V., Marcon, F., Manshian, B.B., Mertens 9, B., Nikolopoulou, D., Raitano, G., Roncaglioni, A., Santonen, T., Spilioti, E., Spyropoulou, A., Sovadinová, I., et al.. - In: TOXICOLOGY LETTERS. - ISSN 0378-4274. - 423:(2026). [10.1016/j.toxlet.2026.112818]
Integrating New Approach Methodologies (NAMs) into regulatory workflows: insights from a series of Case Studies
C. Catinari
Writing – Original Draft Preparation
;C. L. Battistelli;C. Bossa;
2026
Abstract
The increased development and availability of New Approach Methodologies (NAMs) provide a path towards more sustainable, human relevant, and mechanistically based strategies for chemical hazard and risk assessment [1]. However, their regulatory uptake in this context remains limited and further efforts for building confidence in NAM use for decision making are still required [2]. In the context of PARC (European Partnership for the Assessment of Risk from Chemicals) we investigate how NAM-based approaches as well as NAM-derived evidence may support hazard and risk assessment by conducting a coordinated series of case studies that explore key regulatory contexts, purposes, and targeted toxicological endpoints. The purpose is to test NAM-based strategies in realistic decision scenarios to clarify whether implementation is already feasible, in which cases methodological refinements are still required and to define key criteria to ensure their regulatory relevance. The findings are designed to strengthen regulatory acceptance by providing rigorously structured and fully transparent demonstrations of how the NAM-based approaches can be applied across various regulatory contexts (e.g., Occupational Safety and Health directives, Plant Protection Products, CLP and REACH regulations) [3]. The project collects nine case study (CS) proposals designed considering key elements, such as biological coverage, predictivity, chemical applicability domain and the evaluation of data gaps and uncertainties, to ensure the applicability and added value of the NAM-based approaches for regulatory decision-making. All CSs are categorized according to their intended regulatory use, including quantitative in-vitro to in-vivo extrapolation, screening/ prioritization, point-of-departure derivation and specific toxicological endpoints (e.g., carcinogenicity, developmental neurotoxicity, endocrine toxicity, respiratory irritation, developmental and reproductive toxicity). A structured set of guiding questions is established to refine the CSs, with strong emphasis on key aspects such as data availability, harmonized use of data quality assessment tools, evaluation of method reliability, relevance and readiness according to OECD Guidance Document 34, chemical selection criteria, data modelling and integration strategies, and the regulatory relevance of the expected results. Overall, the project will work towards building a structured and pragmatic framework for implementing NAMs into regulatory hazard and risk assessment. Ongoing dialogue with regulatory stakeholders will ensure alignment with regulatory expectations [4]. The project will also describe priority areas for advancing NAM uptake, including the need for robust evaluation criteria and increased regulatory harmonization, while informing the consideration of NAM-based approaches within the OECD Test Guideline Programme. This project is co-funded by PARC (European Partnership for the Assessment of Risk from Chemicals).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


